Inactive Instrument

Highlights XOMA Corp Nasdaq

Equities

US98419J1079

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Earnings Flash (XOMA) XOMA CORPORATION Reports Q1 Revenue $1.5M	05-09	MT
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
XOMA Corporation completed the acquisition of three First-in-Category Assets of Daré Bioscience, Inc. for $22 million.	04-29	CI
XOMA Corporation completed the acquisition of Kinnate Biopharma Inc..	04-02	CI
XOMA Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	03-08	CI
XOMA Agrees to Acquire Kinnate Biopharma	02-16	MT
XOMA Corporation entered into a definitive merger agreement to acquire Kinnate Biopharma Inc. for approximately $120 million.	02-15	CI
XOMA Corporation acquired DSUVIA® of Talphera, Inc. for $8 million.	01-17	CI
Xoma to Make $1 Million Milestone Payment to LadRx After FDA Accepts Zevra Application for Arimoclomol	01-11	DJ
XOMA Authorizes $50 Million Share Buyback Program	01-02	MT
XOMA Authorizes $50 Million Share Buyback Program	01-02	MT
XOMA Corporation announces an Equity Buyback for $50 million worth of its shares.	01-02	CI
XOMA Corporation authorizes a Buyback Plan.	01-01	CI
XOMA Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Earnings Flash (XOMA) XOMA CORPORATION Reports Q3 Revenue $830,000	11-07	MT
ObsEva to Return Global Rights on Ebopiprant to Xoma	23-10-30	MT
Earnings Flash (XOMA) XOMA CORPORATION Posts Q2 Revenue $1.7M	23-08-08	MT
XOMA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI
XOMA Acquires Royalty, Milestone Rights for Two Assets From LadRx	23-06-22	MT
XOMA Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights XOMA Corp Nasdaq

Equities

US98419J1079

Highlights

Filters